| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Zebularine | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.026 | 0.9 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |